Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mirror Image who wrote (1762)	3/16/2016 8:42:01 PM
From: mokelumne river	Read Replies (1) of 2026

MI, thanks for the link to the Taglich report. It was pretty Vitaros-centric, but that is the product that Apricus is selling and the reason most of us old timers invested. I will be very pleased if their revenue projections are close to reality. It would be nice to see a sales milestone sometime in the near future. I keep wanting clarity on how much the phase III clinical trial on Fis is going to set the company back (assuming that the results support such a trial). This report was pretty skimpy in that area. Perhaps we will find out by the end of the month with the phase II results. James

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next